Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis
Titel:
Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis
Auteur:
Kang, Byung Woog Kim, Tae Won Lee, Jae-Lyun Ryu, Min-Hee Chang, Heung Moon Yu, Chang Sik Kim, Jin Cheon Kim, Jong Hoon Kang, Yoon-Koo Lee, Jung Shin